| Systematic (IUPAC) name | |
|---|---|
| 3-methyl-3-[3-(methylamino)propyl]-1-phenyl-1,3-dihydro-2H-indol-2-one | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | ? |
| Identifiers | |
| CAS number | 22136-26-1 22232-73-1 (HCl) |
| ATC code | None |
| PubChem | CID 31075 |
| ChemSpider | 28832 |
| UNII | 2OWK6X9N16 |
| Chemical data | |
| Formula | C19H22N2O |
| Mol. mass | 294.39 g/mol |
| SMILES | eMolecules & PubChem |
|
|
| |
|
Amedalin (UK-3540-1) is an antidepressant which was synthesized in the early 1970s, but was never marketed.[1][2] It is a selective norepinephrine reuptake inhibitor, with no significant effects on the reuptake of serotonin and dopamine, and no antihistamine or anticholinergic properties.[2] [3]
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| This article about an amine is a stub. You can help Wikipedia by expanding it. |
| This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
This entry is from Wikipedia, the leading user-contributed encyclopedia. It may not have been reviewed by professional editors (see full disclaimer)